Role of presynaptic calcium stores for neural network dysfunction in Alzheimer's disease

正Alzheimer’s disease(AD)is the most common form of dementia representing a major problem for public health.In 2017 there were an estimated 50 million patients worldwide and this number is expected to almost double every 20years,reaching 75 million in 2030 and 131.5 million in 2050(https://www.alz.co.uk/research/statistics).Clinically there are two forms of the disease:the     

Impairment of in vivo calcium signaling in amyloid plaque-associated microglia

Neuroinflammation is a hallmark of Alzheimer’s disease (AD) both in man and in multiple mouse models, and epidemiological studies link the use of anti-inflammatory drugs with a reduced risk of developing the disease. AD-related neuroinflammation is largely mediated by microglia, the main immune cells of the central nervous system. In vitro, executive functions of microglia are regulated by intracellular Ca²⁺ signals, but little is known about microglial Ca²⁺ signaling in vivo. Here we analyze in vivo properties of these cells in two mouse models of AD. In both strains plaque-associated microglia had hypertrophic/amoeboid morphology and were strongly positive for markers of activation such as CD11b and CD68. Activated microglia failed to respond reliably to extracellular release of adenosine triphosphate (ATP, mimicking tissue damage) and showed an increased incidence of spontaneous intracellular Ca²⁺ transients. These Ca²⁺ transients required activation of ATP receptors and Ca²⁺ release from the intracellular Ca²⁺ stores, and were not induced by neuronal or astrocytic hyperactivity. Neuronal silencing, however, selectively increased the frequency of Ca²⁺ transients in plaque-associated microglia. Thus, our in vivo data reveal substantial dysfunction of plaque-associated microglia and identify a novel Ca²⁺ signal possibly triggering a Ca²⁺-dependent release of toxic species in the plaque vicinity.